Among different factors, the activation of NF-κB and the overexpression of ABC transmembrane proteins have emerged as crucial contributors to tumor cell resistance against chemotherapy (Ferreira et al. 2017; Fan et al. 2018; Li et al. 2019). This evidence concerns the gene NFKB1 and neoplasm.